CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues:
Product revenue, net	$ 212,802	$ 14,638	$ 350,052	$ 14,638
Operating expenses:
Cost of sales	9,065	636	13,578	636
Research and development	54,081	71,091	98,253	142,328
Selling, general and administrative	196,858	105,448	364,734	186,249
Total operating expenses	260,004	177,175	476,565	329,213
Loss from operations	(47,202)	(162,537)	(126,513)	(314,575)
Interest income	8,227	14,222	17,597	22,556
Interest expense	(3,264)	(3,656)	(6,561)	(7,493)
Other expense	(42)	0	(42)	0
Net loss	$ (42,281)	$ (151,971)	$ (115,519)	$ (299,512)
Net loss per common share:
Basic net loss per common share (in dollars per share)	$ (1.90)	$ (7.10)	$ (5.22)	$ (14.47)
Diluted net loss per common share (in dollars per share)	$ (1.90)	$ (7.10)	$ (5.22)	$ (14.47)
Basic weighted average number of common shares outstanding (in shares)	22,207,017	21,402,646	22,149,492	20,702,041
Diluted weighted average number of common shares outstanding (in shares)	22,207,017	21,402,646	22,149,492	20,702,041